Last reviewed · How we verify
placebo of acetaminophen IV
placebo of acetaminophen IV is a Small molecule drug developed by Nantes University Hospital. It is currently FDA-approved for Control comparator in clinical trials of acetaminophen IV.
A placebo formulation containing no active pharmaceutical ingredient, used as a control comparator in clinical trials.
A placebo formulation containing no active pharmaceutical ingredient, used as a control comparator in clinical trials. Used for Control comparator in clinical trials of acetaminophen IV.
At a glance
| Generic name | placebo of acetaminophen IV |
|---|---|
| Sponsor | Nantes University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
This is a placebo of acetaminophen administered intravenously, meaning it is an inactive control preparation designed to match the appearance and administration route of the active acetaminophen IV formulation. Placebos are used in randomized controlled trials to isolate the true therapeutic effect of the active drug by controlling for expectancy and other non-specific effects.
Approved indications
- Control comparator in clinical trials of acetaminophen IV
Common side effects
Key clinical trials
- Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters (PHASE2)
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants (PHASE2)
- Optimizing Pain Treatment in Children On Mechanical Ventilation (PHASE3)
- A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis (PHASE3)
- Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) (PHASE2)
- Elective Total Abdominal Hysterectomy With Preoperative Analgesia Intravenous Paracetamol Versus Placebo (NA)
- PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients (PHASE3)
- A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo of acetaminophen IV CI brief — competitive landscape report
- placebo of acetaminophen IV updates RSS · CI watch RSS
- Nantes University Hospital portfolio CI